At home, it’s easier to manage essential tremor. We designed a study to meet you there. Learn more about the Essential3 Study.
The Essential3 study has been designed so that you may participate from the comfort of your own home. Learn more about how this fully decentralized study is implemented.
Praxis is excited to share with the essential tremor community that we collaborated with the Lifetime television show, The Balancing Act, to raise awareness about essential tremor and its impact on patients’ daily lives.
We are excited to share the Essential1 topline data with the essential tremor (ET) community: Results show potential for ulixacaltamide (previously PRAX-944) to transform the treatment of essential tremor (ET).
© 2023 Praxis Precision Medicines, Inc.